Jaejik Kim - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jaejik Kim

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Neoplasia (New York, N.Y.)|April 22, 2014

SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cellsSungguan Hong, Hyangsoon Noh, Yong Teng, et al.

Neoplasia (New York, N.Y.)|September 13, 2013

COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesisJing Shao, Yong Teng, Ravi Padia, et al.

Cancer Immunology Research|March 8, 2017

Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast CancersSatish K Noonepalle, Franklin Gu, Eun-Joon Lee, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Neoplasia (New York, N.Y.)|April 22, 2014

SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cellsSungguan Hong, Hyangsoon Noh, Yong Teng, et al.

Neoplasia (New York, N.Y.)|September 13, 2013

COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesisJing Shao, Yong Teng, Ravi Padia, et al.

Cancer Immunology Research|March 8, 2017

Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast CancersSatish K Noonepalle, Franklin Gu, Eun-Joon Lee, et al.

Pageof 2